Lung Cancer: How Well We Have Fared?
Keywords:Adenocarcinoma, Chemotherapy, EGFR, Lung cancer, Driver mutations
Lung Cancer has been one of the most common causes of death worldwide. With the death toll increasing in millions every year globally it has become a global scourge. With poor prognosis and disappointing 5 years survival rate post diagnosis, treatment for this disease has been ambiguous. Various advances in treatment are being made but till date the 5 years survival for major patients remains a dream. This review encompasses different treatment options that are available, problems associated with treatment and future perspective for the treatment of lung cancer. © 2022 iGlobal Research and Publishing Foundation. All rights reserved.